204 related articles for article (PubMed ID: 31871111)
1. FOXA1 Protein Expression in ER
Cheng TD; Yao S; Omilian AR; Khoury T; Buas MF; Payne-Ondracek R; Sribenja S; Bshara W; Hong CC; Bandera EV; Davis W; Higgins MJ; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):379-385. PubMed ID: 31871111
[TBL] [Abstract][Full Text] [Related]
2. FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
Espinal AC; Buas MF; Wang D; Cheng DT; Sucheston-Campbell L; Hu Q; Yan L; Payne-Ondracek R; Cortes E; Tang L; Gong Z; Zirpoli G; Khoury T; Yao S; Omilian A; Demissie K; Bandera EV; Liu S; Ambrosone CB; Higgins MJ
Breast Cancer Res Treat; 2017 Nov; 166(2):559-568. PubMed ID: 28756535
[TBL] [Abstract][Full Text] [Related]
3. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV
Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438
[TBL] [Abstract][Full Text] [Related]
4. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
[TBL] [Abstract][Full Text] [Related]
5. Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice.
Ambrosone CB; Higgins MJ
Cancer Res; 2020 Nov; 80(22):4871-4877. PubMed ID: 32816853
[TBL] [Abstract][Full Text] [Related]
6. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies.
Fortner RT; Sisti J; Chai B; Collins LC; Rosner B; Hankinson SE; Tamimi RM; Eliassen AH
Breast Cancer Res; 2019 Mar; 21(1):40. PubMed ID: 30867002
[TBL] [Abstract][Full Text] [Related]
7. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
Jing X; Liang H; Hao C; Hongxia L; Cui X
Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
[TBL] [Abstract][Full Text] [Related]
9. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.
Palmer JR; Boggs DA; Wise LA; Ambrosone CB; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1883-91. PubMed ID: 21846820
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
11. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
[TBL] [Abstract][Full Text] [Related]
12. FOXA1 represses the molecular phenotype of basal breast cancer cells.
Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.
Ghosh S; Gu F; Wang CM; Lin CL; Liu J; Wang H; Ravdin P; Hu Y; Huang TH; Li R
Breast Cancer Res Treat; 2014 Oct; 147(3):653-9. PubMed ID: 25234841
[TBL] [Abstract][Full Text] [Related]
15. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.
Palmer JR; Viscidi E; Troester MA; Hong CC; Schedin P; Bethea TN; Bandera EV; Borges V; McKinnon C; Haiman CA; Lunetta K; Kolonel LN; Rosenberg L; Olshan AF; Ambrosone CB
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25224496
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
[TBL] [Abstract][Full Text] [Related]
17. Breast feeding, parity and breast cancer subtypes in a Spanish cohort.
Redondo CM; Gago-Domínguez M; Ponte SM; Castelo ME; Jiang X; García AA; Fernández MP; Tomé MA; Fraga M; Gude F; Martínez ME; Garzón VM; Carracedo Á; Castelao JE
PLoS One; 2012; 7(7):e40543. PubMed ID: 22792365
[TBL] [Abstract][Full Text] [Related]
18. FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
Xu C; Wei Q; Guo J; Zhou JC; Mei J; Jiang ZN; Shen JG; Wang LB
Ann Surg Oncol; 2015; 22(6):2034-9. PubMed ID: 25707489
[TBL] [Abstract][Full Text] [Related]
19. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA;
Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
